Comparing Use of a Digital Health System of Pelvic Floor Exercise Program to Kegel Exercises in Stress Urinary Incontinence



Status:Recruiting
Conditions:Urology, Urology
Therapuetic Areas:Nephrology / Urology
Healthy:No
Age Range:18 - 89
Updated:4/3/2019
Start Date:October 24, 2018
End Date:January 2020
Contact:Samantha Pulliam, MD
Email:sjpulliam@renoviainc.com
Phone:8578913057

Use our guide to learn which trials are right for you!

A Prospective Randomized Efficacy Study Comparing a Pelvic Digital Health System Home Program of Pelvic Floor Muscle Exercise to Kegel Exercises in the Treatment of Stress-Predominant Urinary Incontinence

A randomized controlled trial for patients with stress urinary incontinence or
stress-dominant mixed incontinence. Subjects will be randomized to 8-weeks of home kegel
exercises or 8 weeks of pelvic floor muscle exercises using the leva digital pelvic health
system that includes visual biofeedback via smartphone.

A randomized controlled trial for patients with stress urinary incontinence or
stress-dominant mixed incontinence.Subjects will be randomized to 8-weeks of home kegel
exercises or 8 weeks of pelvic floor muscle exercises using the leva digital pelvic health
system that includes visual biofeedback via smartphone. Leva subjects will perform guided
pelvic floor muscle exercises for 2 1/2 minutes twice daily. Home kegel subjects will perform
kegel exercises three times daily. Following 8-weeks of training, subjects will be permitted
to continue the exercises or pursue additional therapies as indicated. Subjects randomized to
the leva digital health system will be further randomized to receive automated reminders for
the remainder of one year, or no additional reminders.

Inclusion Criteria:

- Capable of giving informed consent.

- Self-reported stress-type UI symptoms of >= three months duration

- Diagnosis of stress predominant urinary incontinence based on MESA stress symptom
score greater than MESA urge symptom score (percent of total possible urge score).

- UDI-6 score >/= 25

- Willing to participate in the 8-week study with follow up at 6-and 12-months,
refraining from the pursuit of treatment for Stress Urinary Incontinence using other
modalities (i.e. will not wear a pessary, participate in pelvic floor PT or surgery)
during the first 8- weeks.

Exclusion Criteria:

- Absence of a vagina.

- Age <18 years.

- Stage 3-4 pelvic organ prolapse (as determined by POP-Q).

- Diagnosis of any neuromuscular disease.

- Non-ambulatory.

- Currently pregnant or <12 months post-partum.

-
- Previous pelvic floor muscle training (PFMT) within the last 12 months under a
supervised therapeutic plan of care.

- Currently taking, or has taken within the last 2 months, medication to treat urinary
incontinence.

- Prior augmentation cystoplasty or artificial sphincter.

- Implanted nerve stimulator for urinary symptoms.

- Participation in another clinical study within 30 days of screening.

- Impaired cognitive function.

- Contraindication to the use of a vaginal probe.

- Unable to understand instructions on the use of the leva® Plus Pelvic Digital Health
System.

- Unable to actively recruit the pelvic floor muscles to any degree for attempted
volitional contraction.
We found this trial at
6
sites
Beverly Hills, California 90021
Principal Investigator: Jennifer Anger, MD
Phone: 310-385-2993
?
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
185 Cambridge Street
Boston, Massachusetts 02114
617-724-5200
Principal Investigator: Milena Weinstein, MD
?
mi
from
Boston, MA
Click here to add this to my saved trials
9500 Euclid Avenue
Cleveland, Ohio 44106
216.444.2200
Principal Investigator: Marie Paraiso, MD
Phone: 261-444-3428
Cleveland Clinic Cleveland Clinic is committed to principles as presented in the United Nations Global...
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
Birmingham, Alabama 35294
Principal Investigator: Holly Richter, MD
Phone: 205-934-1704
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
303 East Superior Street
Chicago, Illinois 60611
Principal Investigator: Sarah Collins, MD
Phone: 312-926-7846
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Oklahoma City, Oklahoma 73104
Principal Investigator: Lieschen Quiroz, MD
Phone: 405-271-8001
?
mi
from
Oklahoma City, OK
Click here to add this to my saved trials